TGF-β is an important regulator of physiological fibrogenesis for lesion healing and tissue repair, and its deregulated function and the deregulated expression of TGF-β-linked genes have been documented in fibrotic tissues of SSc patients and correlate with the disease activity [8,67]. This evidence concerns the gene TGFB1 and systemic sclerosis.